WebJan 1, 2024 · Eplerenone was safe but not superior to placebo in improving best corrected visual acuity in people with chronic central serous chorioretinopathy during 12 months … WebApr 8, 2024 · Blogs Central serous retinopathy occurs in middle-age adults, typically spontaneously, and is associated with accumulation of fluid below the retina. It can be commonly mistaken for age ...

Oral Spironolactone versus Conservative Treatment for Non …

WebBackground: The pathogenesis of central serous chorioretinopathy (CSC) is still poorly understood. An animal model of CSC proved that the mineralocorticoid receptor [1] of the choroid also plays a role in CSC. WebBackground: Eplerenone (Epl) is a selective mineralocorticoid-receptor antagonist used for chronic central serous chorioretinopathy treatment. Our goal was to enhance the corneal performance of Epl-loaded nanostructured lipid carriers (NLCs) through surface modification using different coating polymers. gowasu watching television

光相干断层扫描血管成像在中心性浆液性脉络膜视网膜病变量化研 …

WebAbstract Background/aims The efficacy of mineralocorticoid receptor antagonist eplerenone to treat chronic central serous chorioretinopathy (CSCR) has been established. However, previous studies have been limited by small cohort size and short follow-up duration. WebJun 1, 2024 · Central serous chorioretinopathy (CSCR) occurs in middle-aged adults, typically spontaneously, and is associated with the accumulation of subretinal fluid (SRF) and subsequent detachment of... WebIntroduction. Although Central serous chorioretinopathy (CSC) has been associated with various risk factors such as type A behavior, continuous stress, sleeping disturbance, smoking and steroid use; the exact pathogenesis of the disease is still not well ascertained. 1–4 Most cases are acute CSC that usually resolves within 3–4 months. The chronic … go wassail song